DNA methylation is associated with lung function in never smokers.


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
02 Dec 2019
Historique:
received: 09 07 2019
accepted: 22 10 2019
entrez: 4 12 2019
pubmed: 4 12 2019
medline: 6 5 2020
Statut: epublish

Résumé

Active smoking is the main risk factor for COPD. Here, epigenetic mechanisms may play a role, since cigarette smoking is associated with differential DNA methylation in whole blood. So far, it is unclear whether epigenetics also play a role in subjects with COPD who never smoked. Therefore, we aimed to identify differential DNA methylation associated with lung function in never smokers. We determined epigenome-wide DNA methylation levels of 396,243 CpG-sites (Illumina 450 K) in blood of never smokers in four independent cohorts, LifeLines COPD&C (N = 903), LifeLines DEEP (N = 166), Rotterdam Study (RS)-III (N = 150) and RS-BIOS (N = 206). We meta-analyzed the cohort-specific methylation results to identify differentially methylated CpG-sites with FEV A total of 36 CpG-sites were associated with FEV With the identification of 35 CpG-sites that are unique for never smokers, our study shows that DNA methylation is also associated with FEV

Sections du résumé

BACKGROUND BACKGROUND
Active smoking is the main risk factor for COPD. Here, epigenetic mechanisms may play a role, since cigarette smoking is associated with differential DNA methylation in whole blood. So far, it is unclear whether epigenetics also play a role in subjects with COPD who never smoked. Therefore, we aimed to identify differential DNA methylation associated with lung function in never smokers.
METHODS METHODS
We determined epigenome-wide DNA methylation levels of 396,243 CpG-sites (Illumina 450 K) in blood of never smokers in four independent cohorts, LifeLines COPD&C (N = 903), LifeLines DEEP (N = 166), Rotterdam Study (RS)-III (N = 150) and RS-BIOS (N = 206). We meta-analyzed the cohort-specific methylation results to identify differentially methylated CpG-sites with FEV
RESULTS RESULTS
A total of 36 CpG-sites were associated with FEV
CONCLUSIONS CONCLUSIONS
With the identification of 35 CpG-sites that are unique for never smokers, our study shows that DNA methylation is also associated with FEV

Identifiants

pubmed: 31791327
doi: 10.1186/s12931-019-1222-8
pii: 10.1186/s12931-019-1222-8
pmc: PMC6889726
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

268

Subventions

Organisme : Longfonds
ID : 4.1.13.007

Références

BMC Genet. 2015 Dec 03;16:138
pubmed: 26634245
Genetics. 2014 Nov;198(3):1071-85
pubmed: 25213169
Lancet. 2009 Aug 29;374(9691):733-43
pubmed: 19716966
Occup Environ Med. 2018 Jun;75(6):427-435
pubmed: 29459480
Am J Epidemiol. 2014 Jun 1;179(11):1323-30
pubmed: 24780843
J Allergy Clin Immunol. 2017 Feb;139(2):533-540
pubmed: 27612410
Int J Epidemiol. 2015 Aug;44(4):1388-96
pubmed: 25617346
Circ Cardiovasc Genet. 2016 Oct;9(5):436-447
pubmed: 27651444
Respir Res. 2016 Nov 5;17(1):143
pubmed: 27814717
PLoS Genet. 2012;8(4):e1002629
pubmed: 22532803
BMJ Open Respir Res. 2018 Jun 29;5(1):e000282
pubmed: 30018765
Eur J Epidemiol. 2017 Sep;32(9):807-850
pubmed: 29064009
J Allergy Clin Immunol. 2015 Dec;136(6):1664-1672.e14
pubmed: 25979521
JCI Insight. 2016 Dec 8;1(20):e90151
pubmed: 27942592
Clin Epigenetics. 2017 Dec 21;9:132
pubmed: 29299071
Environ Int. 2017 Nov;108:228-236
pubmed: 28886416
Nat Rev Genet. 2007 Apr;8(4):253-62
pubmed: 17363974
Int J Epidemiol. 2015 Aug;44(4):1172-80
pubmed: 25502107
J Allergy Clin Immunol. 2017 Jul;140(1):14-23
pubmed: 28673400
BMJ Open. 2015 Aug 28;5(8):e006772
pubmed: 26319774
Nat Genet. 2017 Mar;49(3):426-432
pubmed: 28166215
Environ Health Perspect. 2018 Feb 06;126(2):027004
pubmed: 29410382
Eur Respir J. 2019 Jul 4;54(1):null
pubmed: 31073081
Am J Respir Crit Care Med. 2012 Feb 15;185(4):373-81
pubmed: 22161163
Nat Rev Genet. 2012 May 29;13(7):484-92
pubmed: 22641018
Epigenomics. 2017 Jul;9(7):971-984
pubmed: 28621160
Diabetologia. 2016 May;59(5):998-1006
pubmed: 26825526

Auteurs

Maaike de Vries (M)

University of Groningen, University Medical Center Groningen, Department of Epidemiology, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. m.de.vries04@umcg.nl.
University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands. m.de.vries04@umcg.nl.

Ivana Nedeljkovic (I)

Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Diana A van der Plaat (DA)

University of Groningen, University Medical Center Groningen, Department of Epidemiology, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.

Alexandra Zhernakova (A)

University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

Lies Lahousse (L)

Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Bioanalysis, FFW, Ghent University, Ghent, Belgium.

Guy G Brusselle (GG)

Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Najaf Amin (N)

Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Cornelia M van Duijn (CM)

Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Judith M Vonk (JM)

University of Groningen, University Medical Center Groningen, Department of Epidemiology, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.

H Marike Boezen (HM)

University of Groningen, University Medical Center Groningen, Department of Epidemiology, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH